Dr. Reddy's Laboratories (RDY) News Today $75.20 -3.24 (-4.13%) (As of 10/29/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Dr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News SummaryOctober 29 at 5:23 AM | benzinga.comDr. Reddy’s Launches Groundbreaking Drug in IndiaOctober 29 at 12:21 AM | markets.businessinsider.comDr. Reddy's Laboratories rises Monday, still underperforms marketOctober 28 at 7:21 PM | marketwatch.comJourney Medical announces presentation of DFD-29 dataOctober 26, 2024 | markets.businessinsider.comDr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive YearOctober 25, 2024 | businesswire.comDr. Reddy's Laboratories Stock Scheduled to Split on Tuesday, November 5th (NYSE:RDY)October 24, 2024 | americanbankingnews.comDr. Reddy's Laboratories Stock Set to Split on Tuesday, November 5th (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) shares are scheduled to split before the market opens on Tuesday, November 5th. The 5-1 split was announced on Thursday, September 12th. The newly created shares will be payable to shareholders after the market closes on Monday, November 4th.October 24, 2024 | marketbeat.comZacks Research Has Optimistic Outlook of RDY Q2 EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research increased their Q2 2027 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research note issued to investors on Wednesday, October 16th. Zacks Research analyst R. Department now expects that the company wOctober 18, 2024 | marketbeat.comDr. Reddy's Laboratories outperforms market despite losses on the dayOctober 17, 2024 | marketwatch.comZacks Research Comments on Dr. Reddy's Laboratories Limited's Q2 2026 Earnings (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research boosted their Q2 2026 EPS estimates for shares of Dr. Reddy's Laboratories in a research report issued on Wednesday, October 16th. Zacks Research analyst R. Department now anticipates that the compaOctober 17, 2024 | marketbeat.comDr. Reddy's Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness MonthOctober 14, 2024 | businesswire.comArtemis Investment Management LLP Has $4.71 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Artemis Investment Management LLP grew its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 280.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 59,306 shares of the coOctober 10, 2024 | marketbeat.comDr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy TrialOctober 9, 2024 | finance.yahoo.comAurigene Oncology Limited Announces Promising Results of Phase 1 Study for India's First Trial for Novel Autologous CAR-T Cell Therapy for Multiple MyelomaOctober 8, 2024 | businesswire.comDr. Reddy’s Unveils New Danish SubsidiaryOctober 8, 2024 | finance.yahoo.comSei Investments Co. Sells 26,041 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Sei Investments Co. lowered its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 66.8% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,935 shares of the company's stock after selling 26,041 shares during the qOctober 8, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Acquires 283,700 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 318.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 372,900 shOctober 4, 2024 | marketbeat.comCreative Planning Purchases 16,157 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Creative Planning increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 22.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 87,522 shares of the company's stock after buying anOctober 3, 2024 | marketbeat.comDr. Reddy’s Acquires Global NRT Leader NicotinellOctober 1, 2024 | finance.yahoo.comDimensional Fund Advisors LP Increases Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Dimensional Fund Advisors LP lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 12.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,003,782 shares of the company's stock afteSeptember 27, 2024 | marketbeat.comXTX Topco Ltd Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)XTX Topco Ltd acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,305 shares of the company's stock,September 24, 2024 | marketbeat.comAmerican Century Companies Inc. Has $11.19 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)American Century Companies Inc. grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 146,823 shares of the company's stock aSeptember 23, 2024 | marketbeat.com34,557 Shares in Dr. Reddy's Laboratories Limited (NYSE:RDY) Acquired by Frank Rimerman Advisors LLCFrank Rimerman Advisors LLC purchased a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 34,557 shares of the company's stSeptember 22, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) is Promethos Capital LLC's 7th Largest PositionPromethos Capital LLC boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 14.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,734 sharSeptember 20, 2024 | marketbeat.comIndian equity markets suffer losses amid increased selling pressureSeptember 20, 2024 | msn.comMondrian Investment Partners LTD Sells 22,329 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Mondrian Investment Partners LTD decreased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 13.6% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 142,218 shares of the company's stock after selling 22,329 shaSeptember 18, 2024 | marketbeat.comRenaissance Technologies LLC Purchases 65,606 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Renaissance Technologies LLC increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 3.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,995,495 shares of the company's stock aftSeptember 16, 2024 | marketbeat.comRhumbline Advisers Trims Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Rhumbline Advisers reduced its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 19.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 75,643 shares of the company's stock after selling 18,782 shares during the period. Rhumbline Advisers'September 15, 2024 | marketbeat.comNatixis Advisors LLC Purchases New Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Natixis Advisors LLC acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,202 shares of the company's stock, valued atSeptember 13, 2024 | marketbeat.comZacks Research Brokers Lower Earnings Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research lowered their FY2027 EPS estimates for shares of Dr. Reddy's Laboratories in a research note issued on Wednesday, September 11th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3September 12, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (RDY)September 11, 2024 | finance.yahoo.comCaprock Group LLC Invests $997,000 in Dr. Reddy's Laboratories Limited (NYSE:RDY)Caprock Group LLC bought a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,080 shares of the company's stock, valued at appSeptember 11, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Stock Position Increased by Acadian Asset Management LLCAcadian Asset Management LLC increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 37.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 269,131 shares of the company's stoSeptember 10, 2024 | marketbeat.comNational Bank of Canada FI Has $13.88 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)National Bank of Canada FI grew its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 81.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 184,120 shares of the company's stock after purchasSeptember 8, 2024 | marketbeat.comDr. Reddy's Laboratories underperforms Tuesday when compared to competitorsSeptember 3, 2024 | marketwatch.comDr. Reddy's Laboratories Limited (NYSE:RDY) Sees Significant Growth in Short InterestDr. Reddy's Laboratories Limited (NYSE:RDY - Get Free Report) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 2,270,000 shares, an increase of 20.1% from the July 31st total of 1,890,000 shares. Based on an average daily trading volume, of 250,200 shares, the short-interest ratio is currently 9.1 days.September 1, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Cuts Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Allspring Global Investments Holdings LLC decreased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 17.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,260September 1, 2024 | marketbeat.comPanagora Asset Management Inc. Has $11.57 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Panagora Asset Management Inc. raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 20.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 151,841 shares of the company's stock after buying an addiAugust 30, 2024 | marketbeat.comDr. Reddy's Laboratories underperforms Thursday when compared to competitorsAugust 29, 2024 | marketwatch.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. decreased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 62.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,048 shares of the company's stock aftAugust 19, 2024 | marketbeat.comFY2025 EPS Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY) Decreased by Zacks ResearchDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research decreased their FY2025 earnings estimates for shares of Dr. Reddy's Laboratories in a research report issued to clients and investors on Wednesday, August 14th. Zacks Research analyst R. DepartmentAugust 16, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down to $83.32Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down to $83.32August 14, 2024 | marketbeat.comArtemis Investment Management LLP Raises Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Artemis Investment Management LLP grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 92.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,600 shares of the companAugust 12, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month High at $84.03Dr. Reddy's Laboratories (NYSE:RDY) Hits New 1-Year High at $84.03August 7, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Vanguard Group Inc.Vanguard Group Inc. trimmed its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 1.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,019,011 shares of the compaAugust 6, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Jane Street Group LLCJane Street Group LLC raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 2,197.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 113,168 shares of the company's stock after purchasing aAugust 5, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Price Target Raised to $87.00Barclays raised their price objective on shares of Dr. Reddy's Laboratories from $81.00 to $87.00 and gave the company an "overweight" rating in a research note on Tuesday.July 30, 2024 | marketbeat.comBellevue Group AG Sells 20,004 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Bellevue Group AG reduced its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 32.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,896 shares of the company's stock after sellinJuly 29, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month High at $82.89Dr. Reddy's Laboratories (NYSE:RDY) Reaches New 52-Week High at $82.89July 29, 2024 | marketbeat.comDr. Reddy's Q1FY25 Financial ResultsJuly 27, 2024 | businesswire.com Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address This is treason (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.220.67▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼73▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News BioNTech News BeiGene News Teva Pharmaceutical Industries News Ginkgo Bioworks News Moderna News Genmab A/S News Summit Therapeutics News Viatris News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 10/30/2024 by MarketBeat.com Staff From Our Partners625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredIs your portfolio prepared for AI 2.0?AI has exploded ever since ChatGPT set the world on fire near the end of 2022. Numerous companies with conn...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
